Zuwena Namaganda
ID: UNCST-2026-R024328
|
LEGAL PROTECTION AGAINST SEXUAL VIOLENCE IN UGANDA: LESSONS FROM KENYA AND CANADA
REFNo: SS5576ES
Aim of the Study
To critically examine and compare the legal frameworks for the protection of women against sexual violence in Uganda, Kenya, and Canada, with a view to identifying gaps, challenges, and best practices that can inform law reform and improve justice outcomes for survivors.
Objectives of the study
To examine and compare the legal frameworks governing protection against sexual violence in Uganda, Kenya, and Canada.
To assess the effectiveness of the implementation and enforcement of laws relating to sexual violence in Uganda, Kenya, and Canada.
To analyse the legal, institutional, and socio-cultural barriers that hinder women's access to justice in cases of sexual violence in the three jurisdictions.
To identify lessons and best practices from the Kenyan and Canadian legal systems that may strengthen legal protection against sexual violence in Uganda.
|
Uganda |
2026-07-24 8:51:04 |
2029-07-24 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Junior Kasima Senyonga
ID: UNCST-2023-R005699
|
EVALUATION OF BLACK SOLDIER FLY LARVAE-BASED MEAL AS AN ALTERNATIVE PROTEIN SOURCE IN PIG DIETS
REFNo: A790ES
1 To determine the effect of four post-harvest processing methods on nutritional quality of black soldier fly larvae raised on different substrates.
2 To determine the effect of processing of pig feeds containing BSFL-based meal on the shelf-stability of pig feeds containing black soldier fly larvae meal
3 To determine the effect of black soldier fly larvae meal-based diets on the performance of grower pigs
4 To assess the economic feasibility of using black soldier fly larvae meal-based diets in feeding grower pigs.
|
Uganda |
2026-07-24 8:46:38 |
2029-07-24 |
Agricultural Sciences |
Non-Clinical Trial |
Degree Award |
|
Aloysious Ssemaganda
ID: UNCST-2023-R008046
|
SARS-CoV-2 as a Model Pathogen for Rapid Immunosurveillance of Severe Acute Respiratory Illnesses (SARI) and Influenza-Like Illnesses (ILI) in Uganda: A Pilot Platform
REFNo: HS7938ES
Primary Objective
To pilot and establish an integrated immunological surveillance platform in Uganda and the East African region for the real-time functional characterization of circulating variants of SARS-CoV-2 as a model pathogen, creating a scalable framework for future expansion to other SARI and ILI threats.
Specific Objectives
1.
To develop and implement standardized operating procedures (SOPs) for the screening, recruitment, sample collection, transportation, and biobanking of clinical specimens from at least 200 participants presenting with SARI and ILI in Uganda over a 12-month period.
2.
To assess the phenotypic immune escape potential of circulating and newly emergent SARS-CoV-2 variants by quantifying their sensitivity to neutralization by antibodies derived from vaccinated and naturally infected individuals, thereby establishing a workflow applicable to future Influenza and RSV surveillance.
3.
To build sustainable local capacity by training at least 2 NHLDS-CPHL staff in all aspects of the high-throughput pipeline and successfully isolating, expressing, and characterizing variant-specific monoclonal antibodies (mAbs).
|
Uganda |
2026-07-24 8:40:56 |
2029-07-24 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Rawlance Ndejjo
ID: UNCST-2022-R010993
|
Win Win in the Wetlands for Climate Resilience: Consolidating and Scaling Health, Social, and Economic Impacts of Wetlands Conservation and Restoration in rural as well as urban Uganda
REFNo: HS8087ES
3. To evaluate the impact of training programs in strengthening the technical and evaluative capacity of district and city teams to contribute to wetland restoration,2. To co-design, pilot, and evaluate an evidence-based intervention for urban wetland conservation/restoration,1. To evaluate the climate, health, social, and economic impacts of wetland conservation/restoration. ,To systematically evaluate the climate, health, social, and economic benefits of wetland conservation under the BRC project, and adapt and evaluate a participatory restoration model to urban wetlands in Uganda. ,
|
Uganda |
2026-07-24 8:36:43 |
2029-07-24 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
George Kasule William
ID: UNCST-2023-R006891
|
Performance Evaluation of the Pluslife MiniDock MTB Test for Detection of Mycobacterium tuberculosis in high TB/HIV settings in Uganda
REFNo: HS7953ES
GENERAL OBJECTIVE
To evaluate the diagnostic accuracy of the Pluslife MiniDock MTB Test for the detection of Mycobacterium tuberculosis in a high TB-HIV setting in Uganda.
SPECIFIC OBJECTIVES
1. To determine the diagnostic accuracy of Pluslife MiniDock MTB Test compared to GeneXpert MTB/RIF Ultra and mycobacterial culture as reference standards for detection of Mycobacterium tuberculosis in a high TB/HIV setting in Uganda.
2. To compare diagnostic performance of Pluslife MiniDock MTB Test between tongue swab and sputum specimens for MTB detection in hign TB/HIV setting in Uganda.
3. To evaluate operational characteristics of Pluslife MiniDock MTB Test including result turnaround time, invalid/error rate, and ease of use among health facility operators and laboratory personnel.
4. To assess the feasibility and acceptability of Pluslife MiniDock MTB implementation at peripheral health facility level within Uganda's TB diagnostic pathway.
|
Uganda |
2026-07-24 8:33:36 |
2029-07-24 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
.jpeg)
|
Tonny Kiggundu Kiggundu
ID: UNCST-2025-R018920
|
CORPORATE ENVIRONMENTAL SUSTAINABILITY OF LARGE MANUFACTURING FIRMS IN UGANDA
REFNo: SS5550ES
1. To contextualize Corporate Environmental Sustainability in large manufacturing firms.
2. To explore how stakeholders, perceive company’s commitment to environmental wellbeing.
3. To discover how participants, understand the interaction between stakeholder expectations, corporate environmental governance, and CES.
4. To explore how institutional pressures, shape Corporate Environmental Sustainability in large manufacturing firms.
5. To analyze how corporate environmental governance, process institutional pressures to shape CES within large firm.
6. To investigate how corporate environmental governance shapes corporate environmental sustainability outcomes.
|
Uganda |
2026-07-24 8:30:18 |
2029-07-24 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Munezero Jonasi
ID: UNCST-2025-R023113
|
ELUCIDATING THE THERAPEUTIC POTENTIAL OF Markhamia lutea ETHANOLIC AND AQUEOUS EXTRACTS IN A TESTOSTERONE-INDUCED RAT MODEL OF BENIGN PROSTATIC HYPERPLASIA
REFNo: NS1315ES
Main Objective
To elucidate the therapeutic potential of Markhamia lutea ethanolic and aqueous extracts in a testosterone-induced rat model of benign prostatic hyperplasia
Specific objectives
The specific objectives of this study are to:
1.Determine the phytochemical compounds of Markhamia lutea ethanolic and aqueous extracts using liquid chromatography-mass spectrometry
2. Determine the safety of the aqueous and ethanolic bark extracts of Markhamia lutea in testosterone-induced rat model of benign prostatic hyperplasia (BPH) using biochemical tests, hematological and histopathological examination of tissues
3. Assess the therapeutic efficacy of the aqueous and ethanolic bark extracts of Markhamia lutea in testosterone-induced rat model of Benign Prostatic Hyperplasia (BPH) using oxidative, hormonal, and inflammatory markers
4. Elucidate the mechanism of action of the identified bioactive compound using Androgen Receptor (AR) and 5α-Reductase (SRD5A2) proteins.
|
Uganda |
2026-07-24 8:27:19 |
2029-07-24 |
Natural Sciences |
Non-Clinical Trial |
Degree Award |
|
Peter Kisaakye
ID:
|
Co-designing Health Innovations to reach Mobile Men with Co-Morbidities in Uganda
REFNo: HS8036ES
Building on promising approaches to men’s health in sub-Saharan African countries, the HIMM project aims to co-design and validate the feasibility of an intervention to improve men’s access to care for NCD-ID co-morbidity within mobility contexts. Our objectives and research questions are:
1. To explore the spaces, mobility patterns, actors, and livelihood assets shaping men’s access to care for NCD-ID co-morbidities in urban settlements and border towns
RQ1: What social, spatial, and infrastructural factors shape men’s mobility cycles, and how do livelihood assets along these cycles influence health-seeking for NCD-ID co-morbidities?
2. To assess the burden of diabetes, hypertension, and HIV among mobile men and their reported access to screening and treatment
RQ2: What is the burden of diabetes, hypertension, and HIV among mobile men and what are the associations between patterns of mobility and self-reported co-morbidities with clinical assessments of diabetes, hypertension, and HIV?
3. To examine how the evolving agenda on NCD-ID integration is being implemented at the health systems and services level, and experienced by mobile men
RQ3: How responsive are evolving NCD-ID integration policies to men’s mobility in Uganda?
4. To adapt promising strategies for delivering health care services to men for NCD-ID co-morbidities among mobile men
RQ4: How can co-design methodologies be adapted to engage mobile men in developing interventions for their unmet NCD/ID care needs?
5. To validate the feasibility and acceptability of the co-designed intervention and explore contextual factors likely to affect implementation and engagement.
RQ5: What is the perceived feasibility and acceptability of a co-designed intervention to improve access to NCD/ID screening and care for mobile men and what contextual factors are likely to influence implementation and engagement with the intervention?
|
Uganda |
2026-07-24 8:25:43 |
2029-07-24 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Rukundo vicent
ID: UNCST-2025-R023088
|
TERPENOID QUANTIFICATION AND PRODUCT FORMULATION FROM AERIALPARTS OF
AMARANTHUS VIRIDIS FOR THE MANAGEMENT OF SITOPHILUS ZEAMAIS
REFNo: NS1254ES
i. To isolate triterpenoids from aerial parts of A. viridis extracts.
ii. To determine the insecticidal repellency of the isolated triterpenoids against S. zeamais.
iii. To determine the composition and quantity of triterpenoids from aerial parts of A. viridis.
iv. To characterize the chemical structure of the isolated triterpenoids for repelling S. zeamais.
v. To formulate a product using the isolated triterpenoids for the management of S. zeamais.
|
Uganda |
2026-07-24 8:02:57 |
2029-07-24 |
Natural Sciences |
Non-Clinical Trial |
Degree Award |
|
Alfred Yayi
ID: UNCST-2025-R019850
|
Prevalence, Attitudes, and Use of Complementary and Alternative Medicine (CAM) Among Medical Doctors in Asia and Africa.
REFNo: HS7686ES
1.To survey CAM use among Medical Doctors in selected hospitals in Asia and Africa.
2.To investigate Medical Doctors’ attitudes toward CAM in both regions.
3.To examine Medical Doctors’ perceptions of CAM safety, effectiveness, and clinical utility.
4.To compare cross-regional differences in CAM use and predictors of Medical Doctors recommendation.
5.To explore how Medical Doctors’ perceptions and attitudes influence their communication with patients regarding CAM.
|
Uganda |
2026-07-24 8:01:37 |
2029-07-24 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|